China IVD Market, Share, Trends, Regulations, Reimbursement & Key Players Analysis - Forecast to 2025
                     
China IVD Market and Forecast
China In-Vitro Diagnostics (IVD) market is likely to exceed US$ 15 Billion mark by 2025. China is a 
large and fast-growing in vitro diagnostics (IVD) market - in fact, only second to the United States 
in terms of value. Historically, large multinational companies have dominated IVD market in China; 
today, domestic companies such as Shanghai Kehua Bio-Engineering (KHB) being one of the  
largest - are now gaining market share. 
China - IVD Market (Billion US$), 2009-2018
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
China IVD Market and Forecast
China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest 
growing among the top ten IVD country markets. China’s quickly aging population means the country is 
experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these 
conditions can be diagnosed and monitored using IVD products.  Further, the average Chinese consumer 
is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the 
potential for more dramatic growth in the future. 
China  – Forecast for IVD Market (Billion US$), 2019-2025
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
China IVD Market Segment Wise Analysis
• Immunoassay captures maximum By Segment – China IVD Market Share (Percent), 2018
share of the China IVD market.
• Clinical Chemistry holds the 2nd 
position in China IVD market being 
followed by Molecular Testing.
• The molecular testing market in 
China is expected to show double 
digits growth rate during the forecast 
period. By Segment – Forecast for China IVD Market Share (Percent), 2025
• China SMBG market is dominated by 
foreign IVD companies such as Roche.
• Microbiology and Hematology 
segments are competing closely with 
each other to grab maximum share of 
the pie.
• Point of Care Testing accounts for 
least share of the China IVD market.
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
China IVD Market Company Analysis
By Company – China IVD Market Share (Percent), 2018
• Roche captures maximum 
share of the China IVD market. 
• Sysmex Corporation and 
Mindary Medical are other top 
two players in the China IVD 
market.
• Sysmex is expanding its 
business portfolio in China, 
such as by entering the By Company – Forecast for China IVD Market Share (Percent), 2025
immunochemistry field there in 
2015.
• At present, many local players 
are present in China IVD 
market and their combined 
market share is likely to exceed 
54 percent by 2025.
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
Continue (www.igateresearch.com)
iGATE RESEARCH report titled “China IVD Market, Share, Trends, 
Regulations, Reimbursement & Key Players Analysis - Forecast to 
2025” provides a comprehensive analysis of the China In-Vitro 
Diagnostics (IVD) Market.
www.igateresearch.com
This 106 Page report with 34 Figures and 3 Tables has been analyzed from 10 View Points:
1) China IVD Market and Forecast (2009 - 2025)
2) China IVD Market Share and Forecast (2009 - 2025)
3) China IVD Market & Forecast – By Segment (2009 - 2025)
4) Development Environment and Regulatory Status in China IVD market 
5) China IVD Market & Forecast – Key Players Sales Analysis (2010 - 2025)
6) Registration for In Vitro Diagnostic Reagents in China
7) Regulatory History/Status/Trends in China IVD Market
8) Reimbursement of IVD Products in China
9) Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10) China IVD Industry Drivers & Challenges
www.igateresearch.com
Continue (www.igateresearch.com)
China IVD Market – By Application Segments
1. Clinical Chemistry Market 
2. Immunoassay Market 
3. Hematology Market 
4. Coagulation Market 
5. Microbiology Market 
6. Molecular Testing Market
7. Self Monitoring of Blood Glucose (SMBG) Market 
8. Point of Care Testing (POCT) Market
  China IVD Sales & Forecast – Key Players Analysis
1. Roche Diagnostic
2. Abbott Laboratories
3. Sysmex Corporation
4. Mindray Medical International Limited
5. Shanghai Kehua Bio-Engineering Co. Ltd.
6. Others
www.igateresearch.com
Continue (www.igateresearch.com)
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)
www.igateresearch.com
Published By
  iGATE RESEARCH
   Phone: +91-858-684-0791 (India)
               +91-821-092-7469 (India)
   Email: [email protected]
   Internet: www.igateresearch.com
 
 
 
 
 
www.igateresearch.com
Format
Report Title: 
“China IVD Market, Share, Trends, Regulations, Reimbursement 
& Key Players Analysis - Forecast to 2025”
To Order the Report Visit:
http://www.igateresearch.com/
Single User License US$ 1,690
Hard-copy Mail Delivery US$ 1,890
CD-ROM Mail Delivery US$ 1,890
Multi User License US$ 2,490
www.igateresearch.com
Order the Report
iGATE RESEARCH PVT. LTD.
Web: www.igateresearch.com
To order the Report:
E-Mail:  [email protected]
Contact No. : +91-858-684-0791, +91-821-092-7469 (INDIA)
For Report Related Query:
E-Mail:  [email protected]
Contact No. : +91-858-684-0791, +91-821-092-7469 (INDIA)
www.igateresearch.com